Wall Street’s major averages ended the week slightly lower on Friday, losing gains for the week amid renewed optimism about ...

Stocks on Sweden's OMX Stockholm 30 Index held steady at 2,448.97, while Norway's Oslo Exchange Benchmark Index_GI fell 0.6%. Shares in Iceland increased, with the OMX Iceland All-Share PI Equity ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...

Truecaller AB Series B posted the largest decline among large stocks during the session, plunging 12.2%, followed by Sagax AB Series A shares, which plunged 11.5%. Shares of Zealand Pharma A/S ...

Novo Nordisk (NYSE:NVO) reported strong first-quarter results, but lowered its full-year guidance due to ...

New higher loan to value (LTV) expat mortgages are now expanding. Just released, there are now up to 90% LTV mortgages ...

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...

Novo Nordisk A/S NVO reported first-quarter 2025 earnings of 92 cents per American Depositary Receipt (ADR), which matched ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...